Poor Performance of Applicator Tampon‐Based Self‐Collection for Liquid‐Based Cytology Among Women Attending a Tertiary Hospital in South Africa
Open Access
- 12 December 2024
- journal article
- research article
- Published by Wiley in Diagnostic Cytopathology
- Vol. 53 (4) , 150-160
Abstract
Background: The South African Cervical Cancer Prevention and Control Policy was updated in June 2017, recommending liquid‐based cytology (LBC) as the preferred screening method and the investigation of self‐sampling for cervical cancer screening.Aim: To compare the performance of the Self Collection Cervical Health Screening Kit [SelfCerv (applicator tampon)] to the Cervex‐Brush Combi for cytology screening. The study further aimed to compare high‐risk (hr‐) human papillomavirus (HPV) and LBC test results from both methods.Methods: The study included 446 paired samples, comprising self‐collected (SelfCerv) and healthcare provider‐collected (Cervex‐Brush Combi) samples from women aged ≥ 18 years attending gynaecology outpatient clinics at a tertiary hospital in Pretoria, South Africa. LBC slides were prepared using the ThinPrep 5000 processor and manually stained with Hematoxylin and Eosin (H&E). Detection of 14 hr‐HPV types was performed using the Abbott RealTime HR‐HPV assay. Statistical analyses were performed using STATA version 17.0 (Stata Corp., College Station, Texas, USA).Results: A statistically significant difference in cervical cytology detection between the two methods was observed (p = 0.0025). The Cervex‐Brush Combi was more effective in collecting endocervical cells (73.4%; 95% CI: 69.0–77.9) compared to the SelfCerv applicator tampon (7.3%; 95% CI: 4.7–9.9); (p < 0.001). Cytological abnormalities were detected in 65.4% (136/208) of participants who tested positive for hr‐HPV by healthcare provider sampling compared to 40.8% (84/206) by self‐sampling. A fair agreement (κ: 0.35) with a concordance rate of 96.2% (95% CI: 94.4–98.0) was observed for specimen adequacy and diagnosis parameters [κ: 0.34, with a concordance rate of 67.7% (95% CI: 63.2–72.1)] between the two methods.Conclusion: The findings of this study do not support the implementation of applicator tampon‐based self‐collection as a method for cytology‐based cervical cancer screening.Keywords
Funding Information
- Vlaamse Interuniversitaire Raad
- Sefako Makgatho Health Sciences University
This publication has 38 references indexed in Scilit:
- Accuracy of HPV testing on self-collected and clinician-collected samples for different screening strategies in African settings: A systematic review and meta-analysisGynecologic Oncology, 2022
- Commercially available molecular tests for human papillomaviruses: a global overviewClinical Microbiology and Infection, 2020
- A systematic review of self‐sampling for HPV testing in AfricaInternational Journal of Gynecology & Obstetrics, 2020
- Why Consider Self-Sampling for Cervical Cancer Screening in Low- and Middle-Income Countries?AMA Journal of Ethics, 2020
- Self‐collected Pap smears may provide an acceptable and effective method of cervical cancer screeningHealth Science Reports, 2018
- Clinical parameters associated with absence of endocervical/transformation zone component in conventional cervical Papanicolaou smearsTaiwanese Journal of Obstetrics and Gynecology, 2016
- Performance of self-sampled HPV test in comparison with liquid based cytologyEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2014
- The unsatisfactory ThinPrep® Pap Test™: Analysis of technical aspects, most common causes, and recommendations for improvementDiagnostic Cytopathology, 2012
- The significance of endocervical cells and metaplastic squamous cells in liquid-based cervical cytologyDiagnostic Cytopathology, 2009
- Impact of vaccination with Cervarix™ on subsequent HPV-16/18 infection and cervical disease in women 15–25 years of ageGynecologic Oncology, 2008